These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 20390391)

  • 1. Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran.
    Zamani S; Farnia M; Torknejad A; Alaei BA; Gholizadeh M; Kasraee F; Ono-Kihara M; Oba K; Kihara M
    J Urban Health; 2010 Jul; 87(4):603-16. PubMed ID: 20390391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.
    Azbel L; Wegman MP; Polonsky M; Bachireddy C; Meyer J; Shumskaya N; Kurmanalieva A; Dvoryak S; Altice FL
    Int J Prison Health; 2018 Sep; 14(3):175-187. PubMed ID: 30274558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.
    Culbert GJ; Waluyo A; Iriyanti M; Muchransyah AP; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2015 Apr; 149():71-9. PubMed ID: 25659895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran.
    Zamani S; Farnia M; Tavakoli S; Gholizadeh M; Nazari M; Seddighi AA; Setayesh H; Afshar P; Kihara M
    Int J Drug Policy; 2010 May; 21(3):167-72. PubMed ID: 19395250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of drug use, but low rates of HIV risk behaviours among injecting drug users during incarceration in Dutch prisons.
    van Haastrecht HJ; Bax JS; van den Hoek AA
    Addiction; 1998 Sep; 93(9):1417-25. PubMed ID: 9926547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009.
    Navadeh S; Mirzazadeh A; Gouya MM; Farnia M; Alasvand R; Haghdoost AA
    Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii33-6. PubMed ID: 23986417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran.
    Moradi G; Farnia M; Shokoohi M; Shahbazi M; Moazen B; Rahmani K
    Int J Health Policy Manag; 2015 Mar; 4(9):583-9. PubMed ID: 26340487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV testing among incarcerated people with a history of HIV-related high-risk behaviours in Iran: Findings from three consecutive national bio-behavioural surveys.
    Tavakoli F; Parhizgari N; Shokoohi M; Khezri M; Haghdoost AA; Ghasemzadeh I; Bozicevic I; Shahesmaeili A; Nasiri N; Danesh A; Karamouzian M; Sharifi H
    BMC Infect Dis; 2022 Dec; 22(1):907. PubMed ID: 36471282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia.
    Wickersham JA; Zahari MM; Azar MM; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2013 Sep; 132(1-2):378-82. PubMed ID: 23414931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-injection drug use among incarcerated people in Iran: Findings from three consecutive national bio-behavioral surveys.
    Rafiee M; Karamouzian M; Sharifi M; Mirzazadeh A; Khezri M; Haghdoost AA; Mehmandoost S; Sharifi H
    Harm Reduct J; 2024 Aug; 21(1):147. PubMed ID: 39138501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan.
    Huang YF; Kuo HS; Lew-Ting CY; Tian F; Yang CH; Tsai TI; Gange SJ; Nelson KE
    Addiction; 2011 Aug; 106(8):1437-45. PubMed ID: 21438941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: A qualitative study.
    O'Hara GL; Liberman AR; Polonsky M; Azbel L; Marcus R; Doltu S; Cugut S; Altice FL
    J Subst Abuse Treat; 2022 May; 136():108660. PubMed ID: 34801282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome assessment of a triangular clinic as a harm reduction intervention in Rajaee-Shahr Prison, Iran.
    Asl RT; Eshrati B; Dell CA; Taylor K; Afshar P; Kamali M; Mirzazadeh A
    Harm Reduct J; 2013 Dec; 10():41. PubMed ID: 24369092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Within-prison drug injection among HIV-infected Ukrainian prisoners: prevalence and correlates of an extremely high-risk behaviour.
    Izenberg JM; Bachireddy C; Wickersham JA; Soule M; Kiriazova T; Dvoriak S; Altice FL
    Int J Drug Policy; 2014 Sep; 25(5):845-52. PubMed ID: 24951025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and trends of non-medical opioid and other drug use histories among federal correctional inmates in methadone maintenance treatment in Canada.
    Johnson S; MacDonald SF; Cheverie M; Myrick C; Fischer B
    Drug Alcohol Depend; 2012 Jul; 124(1-2):172-6. PubMed ID: 22265193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug use and injection risk-taking among prison methadone maintenance patients.
    Darke S; Kaye S; Finlay-Jones R
    Addiction; 1998 Aug; 93(8):1169-75. PubMed ID: 9813898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.
    Bachireddy C; Shrestha R; Bromberg DJ; Azbel L; Kurmanalieva A; Wegman M; Shumskaya N; Rozanova J; Meyer JP; Altice FL
    Int J Drug Policy; 2022 Mar; 101():103558. PubMed ID: 34915426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent and patterns of drug use in prison in Burkina Faso: findings from a cross-sectional study in central prison of Ouagadougou.
    Traoré K; Cissé K; Diendéré EA; Damiba B; Dao GL; Dao AK; Kaboré A
    Int J Prison Health (2024); 2024 May; 20(2):128-142. PubMed ID: 38984606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prison and Transition Health (PATH) Cohort Study: Study Protocol and Baseline Characteristics of a Cohort of Men with a History of Injecting Drug Use Leaving Prison in Australia.
    Kirwan A; Curtis M; Dietze P; Aitken C; Woods E; Walker S; Kinner S; Ogloff J; Butler T; Stoové M
    J Urban Health; 2019 Jun; 96(3):400-410. PubMed ID: 30989484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.